Sso1 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of Sso1, a member of the SNARE (Soluble NSF Attachment Protein Receptor) family, which is crucial for membrane fusion events in eukaryotic cells. Sso1, primarily found in yeast, functions as a t-SNARE (target SNARE) protein, playing a key role in exocytosis, the process by which cells secrete molecules or transport materials to the cell surface. It operates by forming a complex with v-SNARE (vesicle SNARE) proteins located on vesicles, facilitating the docking and fusion of these vesicles with the plasma membrane. This fusion event is essential for various cellular processes, including protein secretion, membrane repair, and the regulated release of cellular components. Inhibitors of Sso1 interfere with its ability to participate in SNARE complex formation, thereby disrupting membrane fusion and vesicle transport.
The mechanism of action of Sso1 inhibitors typically involves binding to the SNARE domain of the protein, either preventing its interaction with other SNARE proteins or altering its conformation in such a way that it cannot engage in the fusion machinery. Some inhibitors may compete directly with the natural SNARE binding partners, while others may destabilize the protein's structure, rendering it non-functional. By inhibiting Sso1, these compounds disrupt the vesicle docking and fusion processes, which can affect key cellular functions such as secretion, membrane recycling, and intracellular trafficking. Research into Sso1 inhibitors provides valuable insights into the fundamental mechanisms of membrane fusion and how SNARE proteins coordinate the precise control of vesicle transport and exocytosis. This understanding expands the broader knowledge of how cells manage communication, nutrient exchange, and the dynamic regulation of their membrane systems, offering insights into the intricate cellular transport networks.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
N-Ethylmaleimide | 128-53-0 | sc-202719A sc-202719 sc-202719B sc-202719C sc-202719D | 1 g 5 g 25 g 100 g 250 g | $22.00 $68.00 $210.00 $780.00 $1880.00 | 19 | |
A compound that can modify cysteine residues and potentially interfere with SNARE complex formation, indirectly affecting Sso1 function. | ||||||
Pitstop 2 | 1419320-73-2 | sc-507418 | 10 mg | $360.00 | ||
Pitstop 2 inhibits clathrin-mediated endocytosis, potentially influencing vesicle dynamics related to Sso1. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $87.00 | 44 | |
A small molecule that inhibits dynamin, impacting vesicular budding and potentially affecting Sso1-related processes. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Disrupts the structure and function of the Golgi apparatus, potentially influencing vesicular transport involving Sso1. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
A polyether antibiotic that disrupts Golgi function, which could indirectly affect Sso1-mediated vesicle fusion. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Inhibits N-linked glycosylation, impacting protein trafficking and potentially Sso1 function. | ||||||
Golgicide A | 1005036-73-6 | sc-215103 sc-215103A | 5 mg 25 mg | $187.00 $670.00 | 11 | |
A specific inhibitor of the Golgi BFA resistance factor 1 (GBF1), it may affect vesicular transport processes involving Sso1. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $180.00 $299.00 | 59 | |
A compound that stabilizes actin filaments, potentially influencing cytoskeletal dynamics related to Sso1-mediated transport. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A phosphoinositide 3-kinase inhibitor, which could affect vesicle formation and transport, indirectly impacting Sso1 function. | ||||||